Dr. Schackman will describe types of health economics research relevant to substance use disorders and co-occurring conditions, how health economics can be incorporated into clinical trials of screening and treatment interventions, and how health economics researchers can collaborate with substance use disorder researchers conducting observational and implementation studies. Examples will be drawn from Dr. Schackman’s […]
On Wednesday, Arpil 27, 2017, Dr. C. Hendricks Brown, Director of the Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV at Northwestern University, presented “Building the next stage of implementation science to support HIV prevention” as part of the Columbia HIV Center Rounds.
CHERISH director Dr. Schackman presents research on economic evaluations of screening and linkage to care interventions.
Despite growing recognition that substance use disorder is a chronic disease, quality of life is rarely measured in substance use disorder treatment studies. With funding from the National Insitute on Drug Abuse (NIDA) R01DA033424, investigators measured the quality of life in prescription and injection opioid misuse using primary data from a survey of the US […]
On Tuesday, April 12, 2016, Dr. Bruce R. Schackman, Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research at Weill Cornell Medical College and CHERISH director, presented “Perspective from CHERISH: Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV” at the National Drug Abuse Treatment Clinical Trials Network Annual […]
On Tuesday, November 10, 2015, Dr. Benjamin P. Linas, assistant professor of medicine at the Boston University School of Medicine, presented “Understanding access to HCV therapy in 2015” as part of the HepCure Tele-Education Webinar Series.